Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.545 USD | +5.23% | -5.83% | -29.32% |
May. 09 | Goldman Sachs Adjusts Price Target on Clarivate to $7.50 From $8.50, Maintains Buy Rating | MT |
May. 08 | Transcript : Clarivate Plc, Q1 2024 Earnings Call, May 08, 2024 |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The opinion of analysts covering the stock has improved over the past four months.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- Low profitability weakens the company.
- One of the major weak points of the company is its financial situation.
- With an enterprise value anticipated at 3.44 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Professional Information Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-29.32% | 4.16B | B | ||
-4.22% | 134B | A- | ||
+17.67% | 75.42B | B- | ||
-13.29% | 38.47B | B+ | ||
+12.94% | 37.61B | B+ | ||
-0.36% | 30.25B | C+ | ||
-7.93% | 16.77B | B+ | ||
+13.05% | 15.23B | C+ | ||
+10.25% | 10.55B | B | ||
-9.40% | 4.67B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CLVT Stock
- Ratings Clarivate Plc